FACTANKER · measured, cited, anchored official records connected

SEC EDGAR CompanyFacts fact · point in time

INOZYME PHARMA, INC.: common_shares_outstanding

One fact, its scope and the complete path back to the official record.

Period: as of 2022-08-10Status: currentProvenance attached

Cite: FACTANKER, https://factanker.com/fact/4e6a3b6f-b737-4d05-bda2-f6a4c12bc7c2

Reported value

40145674{"unit": "shares", "value": 40145674, "concept": "dei:EntityCommonStockSharesOutstanding"}
Entity
INOZYME PHARMA, INC.
Metric
common_shares_outstanding
Period
as of 2022-08-10
Status
current
Source
SEC EDGAR CompanyFacts

Provenance

Official reference0000950170-22-017233 · Open the official SEC filing →
Source licenseUS-PD-17USC105
Retrieved2026-08-19T17:21:23.824720+02:00
Raw response SHA-256f7bde1a401b286c74a2fd824ee1df541…
Official-identifier pathhttps://factanker.com/fact/sec/cik-0001693011/common-shares-outstanding/2022-08-10 (CIK, metric, reporting date)
History
  • no predecessors — first report

Why this page exists

The UUID above is the stable citation anchor: it never changes, and corrections supersede rather than overwrite. Cite the URL and any reader — human or machine — can verify the value against the official filing.